Literature DB >> 20425828

Molecular and clinical characterization of patients with overlapping 10p deletions.

Anna Lindstrand1, Helena Malmgren, Annapia Verri, Elisa Benetti, Maud Eriksson, Ann Nordgren, Britt-Marie Anderlid, Irina Golovleva, Jacqueline Schoumans, Elisabeth Blennow.   

Abstract

Chromosome 10p terminal deletions have been associated with DiGeorge phenotype, and within the same genomic region haploinsufficiency of GATA3 causes the HDR syndrome (hypoparathyroidism, sensorineural deafness, renal dysplasia). We have performed detailed molecular analysis of four patients with partial overlapping 10p deletions by using FISH-mapping, array-CGH, and custom-designed high-resolution oligonucleotide array. All four patients had mental retardation and speech impairment and three of them showed variable signs of HDR syndrome. In addition, two patients had autistic behaviors and had similar dysmorphic features giving them a striking physical resemblance. A review of the literature identified 10 previously published cases with similar 10p deletions and reliable molecular or molecular cytogenetic mapping data. The combined information of present and previous cases suggests that partial deletions of 10p14-p15 represent a syndrome with a distinct and more severe phenotype than previously assumed. The main characteristics include severe mental retardation, language impairment, autistic behavior, and characteristic clinical features. A critical region involved in mental retardation and speech impairment is defined within 1.6 Mb in 10p15.3. In addition, deletion of 4.3 Mb within 10p14 is associated with autism and characteristic clinical findings.

Entities:  

Mesh:

Year:  2010        PMID: 20425828     DOI: 10.1002/ajmg.a.33366

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  20 in total

Review 1.  The origin and evolution of vertebrate sex chromosomes and dosage compensation.

Authors:  A M Livernois; J A M Graves; P D Waters
Journal:  Heredity (Edinb)       Date:  2011-11-16       Impact factor: 3.821

Review 2.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

3.  Vitamin D deficiency in a patient with HDR syndrome.

Authors:  Ifigenia Kostoglou-Athanassiou; Dimitrios Stefanopoulos; Areti Karfi; Panagiotis Athanassiou
Journal:  BMJ Case Rep       Date:  2015-07-08

4.  GATA3 mutation in a family with hypoparathyroidism, deafness and renal dysplasia syndrome.

Authors:  Zi-Yang Zhu; Qiao-Li Zhou; Shi-Ning Ni; Wei Gu
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

5.  Cleft lip/palate, short stature, and developmental delay in a boy with a 5.6-mb interstitial deletion involving 10p15.3p14.

Authors:  Bruno F Gamba; Carla Rosenberg; Silvia Costa; Antonio Richieri-Costa; Lucilene A Ribeiro-Bicudo
Journal:  Mol Syndromol       Date:  2015-01-22

Review 6.  Genetic insights into the functional elements of language.

Authors:  Adam Szalontai; Katalin Csiszar
Journal:  Hum Genet       Date:  2013-06-08       Impact factor: 4.132

7.  Phenotype comparison confirms ZMYND11 as a critical gene for 10p15.3 microdeletion syndrome.

Authors:  Birute Tumiene; Ž Čiuladaitė; E Preikšaitienė; R Mameniškienė; A Utkus; V Kučinskas
Journal:  J Appl Genet       Date:  2017-09-21       Impact factor: 3.240

8.  Duplication of the Miller-Dieker Critical Region in a Patient with a Subtelomeric Unbalanced Translocation t(10;17)(p15.3;p13.3).

Authors:  R Ruiz Esparza-Garrido; A C Velázquez-Wong; M A Araujo-Solís; J C Huicochea-Montiel; M Á Velázquez-Flores; F Salamanca-Gómez; D J Arenas-Aranda
Journal:  Mol Syndromol       Date:  2012-07-10

9.  Subtelomeric deletion of chromosome 10p15.3: clinical findings and molecular cytogenetic characterization.

Authors:  Cheryl DeScipio; Laura Conlin; Jill Rosenfeld; James Tepperberg; Romela Pasion; Ankita Patel; Marie T McDonald; Swaroop Aradhya; Darlene Ho; Jennifer Goldstein; Marianne McGuire; Surabhi Mulchandani; Livija Medne; Rosemarie Rupps; Alvaro H Serrano; Erik C Thorland; Anne C-H Tsai; Yvonne Hilhorst-Hofstee; Claudia A L Ruivenkamp; Hilde Van Esch; Marie-Claude Addor; Danielle Martinet; Thornton B A Mason; Dinah Clark; Nancy B Spinner; Ian D Krantz
Journal:  Am J Med Genet A       Date:  2012-07-27       Impact factor: 2.802

10.  22q11.2 Deletion Syndrome: Laboratory Diagnosis and TBX1 and FGF8 Mutation Screening.

Authors:  Ilária C Sgardioli; Társis P Vieira; Milena Simioni; Fabíola P Monteiro; Vera L Gil-da-Silva-Lopes
Journal:  J Pediatr Genet       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.